NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

  • July 2021 •
  • 122 pages •
  • Report ID: 5746422 •
  • Format: PDF
KEY FINDINGS
The North America alopecia (hair loss) treatment market is evaluated to record a CAGR of 4.40% over the forecasting period of 2021 to 2028. Key factors such as the growing emphasis on aesthetics, the well-established presence of pharmaceutical firms working towards the effective treatment of alopecia, the rising disposable income, and the increased consumption of alcohol predominantly fuel the regional market’s growth.

MARKET INSIGHTS
The North America alopecia (hair loss) treatment market growth assessment entails the evaluation of Canada and the United States.Canada houses multiple non-profit organizations as well as hair specialist salons endeavoring towards treating alopecia.

In this regard, Canada’s charitable organization named, Canadian Alopecia Areata Foundation (CANAAF) is mainly dedicated to the condition’s treatment.It predominantly extends support to individuals diagnosed with alopecia areata in Canada.

The organization also promotes education and awareness regarding such autoimmune diseases and raises substantial funds for research, as well.
Conversely, Canada has a non-profit organization committed to educating, advocating, and supporting citizens living with alopecia conditions, skin diseases, and traumas.The country also witnesses a considerable rise in smoking and alcohol consumption, resulting in increased hair loss complications among Canadian adults.

As a result, these factors play an essential role in facilitating the North America alopecia (hair loss) treatment market growth over the estimated years.

COMPETITIVE INSIGHTS
Some of the major companies operating in the market are Johnson & Johnson Inc, Concert Pharmaceuticals, Merk & Co Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ACLARIS THERAPEUTICS
2. CELLMID
3. CIPLA LTD
4. CONCERT PHARMACEUTICALS
5. DAIICHI SANKYO
6. DR. REDDY’S LABORATORIES
7. JOHNSON AND JOHNSON
8. LEXINGTON INTERNATIONAL
9. MERK & CO INC
10. SHISEIDO COMPANY LIMITED
11. SUN PHARMACEUTICAL INDUSTRIES LTD
12. TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
13. TEVA PHARMACEUTICALS INDUSTRIES LTD
14. THE HIMALAYA DRUG COMPANY
15. TRANSITION HAIR PVT LTD